Patrick Chaltin
Directeur/Membre du Conseil chez Cytura Therapeutics BV
Profil
Patrick Chaltin is currently a Director at Cytura Therapeutics BV.
He previously worked as a Non-Executive Director at Aratana Therapeutics NV.
He holds a doctorate degree from Katholieke Universiteit Leuven.
Postes actifs de Patrick Chaltin
| Sociétés | Poste | Début |
|---|---|---|
Cytura Therapeutics BV
 Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Anciens postes connus de Patrick Chaltin
| Sociétés | Poste | Fin |
|---|---|---|
Aratana Therapeutics NV
 Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Directeur/Membre du Conseil | - |
Formation de Patrick Chaltin
| Katholieke Universiteit Leuven | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Aratana Therapeutics NV
Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Health Technology |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Commercial Services |
